Literature DB >> 12667817

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

Julia Romanova1, Dietmar Katinger, Boris Ferko, Regina Voglauer, Larisa Mochalova, Nicolai Bovin, Wilina Lim, Hermann Katinger, Andrej Egorov.   

Abstract

Influenza A viruses were isolated in Vero, MDCK cells and chicken embryos. In contrast to MDCK-derived variants all H3N2 isolates obtained in Vero cells neither agglutinated chicken erythrocytes nor grew in chicken eggs. These host range differences of H3N2 Vero and MDCK isolates were noticed even in the absence of amino acid substitutions in the HA1 molecule. Evaluation of HA glycosylation pattern by treatment with endoglycosidases H and F revealed that Vero-variants contained more oligosaccharides of the high mannose type than did the corresponding MDCK-isolates. Removal of some mannose residues from the non-reducing termini of the carbohydrates by exomannosidase treatment resulted in the ability of Vero-isolates to agglutinate chicken erythrocytes. Glycosylation pattern and properties of H3N2 viruses grown in Vero cells were close to those of viruses grown in human kidney epithelial cells, whereas the H1N1 variants isolated from Vero, MDCK cells or eggs did not differ in agglutination properties, carbohydrate composition or ability to infect eggs.

Entities:  

Mesh:

Year:  2003        PMID: 12667817     DOI: 10.1016/s0042-6822(02)00064-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Search for additional influenza virus to cell interactions.

Authors:  E M Rapoport; L V Mochalova; H-J Gabius; J Romanova; N V Bovin
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

Review 2.  Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Authors:  Nagendra R Hegde
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  Cell culture-derived flu vaccine: Present and future.

Authors:  Alberto Pérez Rubio; Jose María Eiros
Journal:  Hum Vaccin Immunother       Date:  2018-06-28       Impact factor: 3.452

5.  Emergence of avian influenza viruses with enhanced transcription activity by a single amino acid substitution in the nucleoprotein during replication in chicken brains.

Authors:  Tatsuya Tada; Koutaro Suzuki; Yu Sakurai; Masanori Kubo; Hironao Okada; Toshihiro Itoh; Kenji Tsukamoto
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

6.  Antimycotic-antibiotic amphotericin B promotes influenza virus replication in cell culture.

Authors:  Elisabeth Roethl; Manuela Gassner; Brigitte M Krenn; Ekaterina A Romanovskaya-Romanko; Helena Seper; Julia Romanova; Sabine Nakowitsch; Sanda Sturlan; Markus Wolschek; Alexej Sirotkin; Oleg Kiselev; Thomas Muster; Andrej Egorov
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus.

Authors:  Chia-Ying Wu; Yi-Chun Yeh; Yu-Chih Yang; Ching Chou; Ming-Tsan Liu; Ho-Sheng Wu; Jia-Tsrong Chan; Pei-Wen Hsiao
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

8.  A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.

Authors:  John Steel; Svetlana V Burmakina; Colleen Thomas; Erica Spackman; Adolfo García-Sastre; David E Swayne; Peter Palese
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641

9.  MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.

Authors:  Ding Yuan Oh; Ian G Barr; Jenny A Mosse; Karen L Laurie
Journal:  J Clin Microbiol       Date:  2008-05-14       Impact factor: 5.948

10.  Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics.

Authors:  Hiroichi Ozaki; Elena A Govorkova; Chenghong Li; Xiaoping Xiong; Robert G Webster; Richard J Webby
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.